Building the Business Case: How Value Analysis Committees Evaluate Patient Transfer Technology

By CEGA | May 2026 | 5 min read

Introduction

For any new medical device to gain traction in a hospital, it must pass through one of the most rigorous internal gatekeeping processes in healthcare: the Value Analysis Committee (VAC). Over the past decade, VACs have become the standard decision-making framework at U.S. hospitals and health systems, replacing the physician-preference purchasing model that dominated for decades prior (symplr, 2025). Their mandate is straightforward—ensure that every product purchased delivers measurable clinical value, operational efficiency, and financial justification.

For clinicians and supply chain professionals evaluating patient transfer technology, understanding the VAC framework is critical. The committee's priorities increasingly align with outcomes-based procurement, creating an opportunity for technologies that can demonstrate total cost of care reduction rather than unit price alone. This article examines the five pillars that VACs use to evaluate patient transfer devices and how air-assisted lateral transfer technology fits within that framework.

The Five Pillars of Value Analysis for Patient Transfer Devices

According to industry research, the three primary priorities of most VACs are expanding purchasing oversight to reduce spend, improving data collection, and engaging clinicians throughout the evaluation process (Advisory Board, 2019). For patient transfer technology specifically, these priorities translate into five evaluation categories.

1. Clinical Outcomes and Patient Safety

VACs begin with a fundamental question: does this device improve patient care? For patient transfer systems, the clinical evaluation centers on measurable harm reduction during and after transfers.

The clinical risks associated with patient handling are well-documented. Post-surgical patients are particularly vulnerable during transfers, when manual repositioning can cause hemodynamic instability (blood pressure fluctuations from tipping), mechanical force on surgical sites, and elevated bleeding risk that may increase susceptibility to surgical site infections. The literature supports a clear mechanical causation chain: device removal requires manual repositioning, manual repositioning applies force at or near wound sites, and that force creates clinical risk.

Air-assisted lateral transfer devices address the first link in that chain—reducing the physical force required to move patients. The critical differentiator among devices in this category, however, is what happens at the point of device removal. Systems that require staff to manually roll or tip the patient to remove the transfer surface reintroduce the very risks the air-assisted transfer was designed to mitigate. Technologies that eliminate direct patient contact during removal - through mechanisms such as CEGA's patented Smart Release Seam - break the causation chain entirely, offering VACs a patient safety argument that extends beyond the transfer itself into the post-procedural recovery period.

2. Caregiver Safety and Injury Reduction

Healthcare worker injuries are among the most expensive and disruptive operational challenges hospitals face. According to the Bureau of Labor Statistics, hospital employees experience a higher incidence of injury and illness - 6.0 cases per 100 full-time workers - than workers in industries traditionally considered more dangerous, including manufacturing and construction (BLS, 2017). Musculoskeletal injuries from patient handling are a primary driver, and OSHA estimates that direct and indirect costs associated with back injuries alone in the healthcare industry reach $20 billion annually (OSHA, Safe Patient Handling).

The economic case is compelling. The National Safety Council reported that the total cost of work injuries across all industries reached $181.4 billion in 2024, with the average cost per medically consulted injury at $48,000 (NSC, 2024). Facilities that have implemented comprehensive safe patient handling programs have demonstrated dramatic results: Erie County Medical Center reported a 50% decrease in workers' compensation claims and a 79% reduction in workers' compensation costs within three years of program implementation; Glen Falls Hospital saw a 56% decrease in handling-related injuries; and the New York State Veterans Home at Batavia achieved a 93% reduction in lost workdays (NYSNA, Safe Patient Handling and Mobility).

OSHA's research supports the broader conclusion that hospitals implementing effective air-assisted transfer technologies can achieve significant reductions in caregiver injuries, with the literature supporting an indirect cost multiplier of two to four times the direct workers' compensation claim cost to estimate the true burden of patient handling injuries (OSHA, 2013).

For VACs, air-assisted transfer devices that reduce the number of staff required per transfer, minimize the force exerted during transfers, and eliminate the manual repositioning step at device removal represent the strongest injury prevention profile in this product category.

3. Workflow Efficiency and Staffing Impact

In an environment of persistent nursing shortages and rising labor costs - the Bureau of Labor Statistics reported total employer compensation costs of $67.64 per hour for hospital workers in June 2024 (BLS, 2024) - any technology that reduces staff-per-task ratios directly impacts operational capacity.

Traditional lateral transfer devices typically require two to four staff members for a single transfer event. Air-assisted systems can reduce this requirement by enabling single-operator or two-person transfers, freeing clinical staff for direct patient care. Technologies that also reduce OR-to-PACU handoff time contribute to faster room turnover and improved throughput - metrics that carry direct revenue implications for surgical programs operating at or near capacity.

The VAC evaluation here is not abstract. Committees quantify the staffing impact in terms of full-time equivalents (FTEs) recovered, overtime hours avoided, and contract labor spend reduced. A device that saves even five minutes per transfer event across hundreds of monthly procedures translates into meaningful labor cost recovery.

4. Infection Control

Surgical site infections (SSIs) remain one of the most costly hospital-acquired conditions. Published estimates place the incremental cost of a single SSI at $12,000 to $30,000 or more depending on severity and patient population (JAMA, Surgical Infection Society data). CMS penalties for hospital-acquired conditions add a reimbursement dimension that makes infection prevention a C-suite priority.

For VACs evaluating patient transfer technology, the infection control analysis focuses on two vectors: cross-contamination risk from reusable devices, and the mechanical risk created during device removal. Reusable transfer surfaces that move between patients create a potential fomite pathway. Single-patient-use (SPU) devices eliminate that vector entirely. Additionally, transfer technologies that require manual lifting or rolling of patients during removal create opportunities for contact with surgical sites, drain sites, and central lines - all documented sources of infection.

Devices designed with disposable, single-patient-use surfaces and contactless removal mechanisms address both infection control vectors simultaneously, giving VACs a defensible clinical rationale that aligns directly with CMS quality metrics and Joint Commission standards.

5. Total Cost of Ownership and ROI

Price is the most frequently cited factor in VAC deliberations (Value in Health, 2015), but sophisticated committees evaluate total cost of care, not unit cost. The distinction matters enormously for patient transfer technology.

The total cost model for a patient transfer device includes the acquisition cost of the device or consumable, staff time per transfer (at fully loaded labor rates), workers' compensation exposure (direct claims and the 2–4× indirect cost multiplier), reprocessing and sterilization costs for reusable devices, clinical complication costs attributable to transfer-related adverse events, and replacement or maintenance costs for capital equipment.

A device with a modestly higher per-unit cost that reduces staffing requirements, eliminates reprocessing, and mitigates complication risk can demonstrate a lower total cost of care than a cheaper alternative that creates hidden cost exposure across multiple budget lines. The American Nurses Association and OSHA have both documented that safe patient handling programs, including air-assisted transfer technology, typically achieve breakeven within one to two years when measured against workers' compensation savings alone (American Nurse Journal, 2019).

For hospitals evaluating REMUV against incumbent products, CEGA Innovations provides facility-specific ROI modeling and value analysis support to quantify projected savings, ensuring that committee decisions are grounded in total cost of care rather than unit price comparison.

What This Means for Your Facility

Value Analysis Committees exist to ensure that purchasing decisions serve patients, clinicians, and the institution's financial health simultaneously. The evaluation framework is rigorous by design, and it rewards technologies that can demonstrate measurable impact across all five pillars - clinical outcomes, caregiver safety, workflow efficiency, infection control, and total cost of ownership.

Air-assisted lateral transfer is not a new category. But the standard of care within that category is evolving. Technologies that address only the transfer event itself - without accounting for the clinical risk created during device removal -

leave a gap in the value proposition that VACs are increasingly equipped to identify and penalize.

CEGA's REMUV Air Lateral Transfer System is designed to close that gap. The patented Smart Release Seam eliminates the need for manual repositioning at device removal, breaking the mechanical causation chain that links transfer technology to post-procedural complications. Combined with single-patient-use infection control, reduced staffing requirements, and cost-neutral conversion economics, REMUV offers a comprehensive value story that is built for the way hospitals actually make purchasing decisions.

References

• Advisory Board. (2019). Value Analysis Committee Survey: Priorities and Practices. Referenced in Medical Product Outsourcing (2025) and Orthopedic Design & Technology (2024).

• American Nurse Journal. (2019). Safe Patient-Handling Programs: How to Calculate Return on Investment. Retrieved from www.myamericannurse.com.

• Bureau of Labor Statistics. (2017). Hospital Workers: An Assessment of Occupational Injuries and Illnesses. Monthly Labor Review. Retrieved from www.bls.gov.

• Bureau of Labor Statistics. (2024). Compensation Costs $67.64 per Hour in Hospitals, June 2024. The Economics Daily. Retrieved from www.bls.gov.

• National Safety Council. (2024). Work Injury Costs. Injury Facts. Retrieved from injuryfacts.nsc.org.

• NYSNA. (n.d.). Safe Patient Handling and Mobility. New York State Nurses Association. Retrieved from www.nysna.org.

• OSHA. (n.d.). Business Case for Safety and Health. Occupational Safety and Health Administration. Retrieved from www.osha.gov/businesscase.

• OSHA. (2013). Caring for Our Caregivers: Safe Patient Handling Programs, Effectiveness and Cost Savings. Retrieved from www.osha.gov.

• OSHA. (n.d.). Healthcare — Safe Patient Handling. Retrieved from www.osha.gov/healthcare/safe-patient-handling.

• symplr. (2025). Quick Guide to Understanding the Hospital Value Analysis Committee. Retrieved from www.symplr.com.

• Value in Health. (2015). The Rise of the Value Analysis Committee at US Hospitals. Vol. 18, Issue 3.

For hospitals looking to build a complete value analysis case for air-assisted lateral transfer technology, contact CEGA Innovations at sales@CEGACO.com or call 800-440-5605.